Responses
Oral Communication 1 – Gynaecological Cancer
Maintenance olaparib after platinum-based chemotherapy in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: efficacy by the timing of surgery and residual tumour status following upfront or interval cytoreductive surgery in the Phase III SOLO1 trial
Compose a Response to This Article
Other responses
No responses have been published for this article.